Summary
Severe aplastic anemia developed in a patient after administration of quinacrine for treatment of discoid lupus erythematosus. Marrow transplantation was performed from an HLA genotypically identical sister after conditioning with cyclophosphamide. Quinacrine which was accumulated in the patient tissues did not interfere with engraftment, suggesting that the drug has no direct cytotoxic effect on hematopoietic stem cells. This study extends our previous observation that severe aplastic anemia acquired after exposure to drugs or toxins can be cured by marrow transplantation.
Similar content being viewed by others
References
Anasetti C, Doney K, Storb R, Meyers JD, Farewell VT, Buckner CD, Appelbaum FR, Sullivan KM, Clift RA, Deeg HJ, Fefer A, Martin PJ, Singer JW, Sanders JE, Stewart PS, Witherspoon RP, Thomas ED (1986) Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty “untransfused” patients. Ann Int Med 104: 461–466
Biro L, Leone N (1965) Aplastic anemia induced by quinacrine. Arch Dermatol 92: 574–576
Bithell TC, Wintrobe MM (1967) Drug-induced aplastic anemia. Semin Hematol 4: 194
Böttiger LE, Westerholm B (1972) Aplastic anemia. II. Druginduced aplastic anemia. Acta Med Scand 192: 319
Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, Rappeport JM, Storb R (1976) Severe aplastic anemia: A prospective study of the effect of early marrow transplantation on acute mortality. Blood 48: 63–70
Custer RP (1946) Aplastic anemia in soldiers treated with atabrine (quinacrine). Am J Med Soc 212: 211–224
Dutrillaux B, Lejeune J (1975) New techniques in the study of human chromosomes: methods and application. Adv Hum Genet 5: 119
Findley GM (1951) Recent advances in chemotherapy, Vol II. Churchill, London, pp 222–223
Fishman A, Kinsman JM (1949) Hypoplastic anemia due to atabrine. Blood 4: 970
Freedman A (1956) Mepacrine versus chloroquine. Ann Rheum Dis 15: 251
Freedman A, Bach F (1952) Mepacrine and rheumatoid arthritis. Lancet 263: 321
Gebster LT (1985) Drugs used in the chemotherapy of protozoal infections (amebiasis, giardiasis and trichomoniasis). In: Goodman, Gilman A, Goodman LS, Rall ThW, Murad F (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 1049–1057
Heimpel H, Heit W (1980) Drug-induced aplastic anemia: clinical aspects. Clin Haematol 9: 641–62
Mainland D, Sutcliffe MI (1962) Hydroxy-chloroquine sulfate in rheumatoid arthritis, a six months double-blind trial. Bull Rheum Dis 13: 287
Namiuchi S, Kumagai S, Imura H, Suginoshila T, Hallori T, Hirata F (1984) Quinacrine inhibits the primary but not secondary proliferative response of human cytotoxic T cells to allogeneic non-T-cell antigens. J Immunol 132: 1456–61
Pachman U, Rigler R (1972) Quantum yield of acridines interacting with DNA of defined base sequence. Exp Cell Res 72: 602
Page F (1951) Treatment of lupus erythematosus with mepacrine. Lancet 261: 755–58
Parmer LG (1984) Blood and bone marrow concentration of atabrine and its role in aplastic anemia. J Lab Clin Med 33: 827–832
Parmer LG, Sawitsky A (1953) Fatal aplastic anemia following quinacrine therapy in chronic discoid lupus erythematosus. JAMA 13: 272–74
Paton MD, Ridell MJ, Strong JA (1955) Aplastic anemia following mepacrine treatment of lupus erythematosus. Lancet I: 281
Powell RD (1966) The chemotherapy of malaria. Clin Pharmacol Ther 7: 48
Schur PH (1971) Systemic lupus erythematosus. In: Beeson PS, McCermott W, Wyngaarden JB (eds) Textbook of medicine. Saunders, Philadelphia
Storb R, Thomas ED, Buckner CD, Appelbaum FR, Clift RA, Deeg HJ, Doney K, Hansen JA, Prentice PL, Sanders JE, Stewart P, Sullivan KM, Witherspoon RP (1984) Marrow transplantation for aplastic anemia. Semin Hematol 21: 27–35
Vencent PC (1986) Drug-induced anemia and agranulocytosis. Incidence and mechanisms. Drugs 31: 52–63
Wilkinson DS (1954) Vascular basis of some nodular cruptions of legs. Br J Dermatol 66: 201–213
Wolfe MS, Wintrobe MM (1975) Giardiasis. JAMA 233: 1362–1365
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmid, I., Anasetti, C., Petersen, F.B. et al. Marrow transplantation for severe aplastic anemia associated with exposure to quinacrine. Blut 61, 52–54 (1990). https://doi.org/10.1007/BF02076699
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02076699